Jose A. Ortega-Ruiz
Barakaldo, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Sex-Dependent Dynamics of Behavioural and Neuropathological Changes in an A53T Alpha-Synuclein Mouse Model of Parkinson's Disease.
Journal: Cellular and molecular neurobiology
Published: December 21, 2025
Temporal progression of pathological features in an α-synuclein overexpression model of Parkinson's disease.
Journal: Brain structure & function
Published: March 14, 2025
Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment.
Journal: International review of neurobiology
Published: October 13, 2023
Automated procedure to detect subtle motor alterations in the balance beam test in a mouse model of early Parkinson's disease.
Journal: Scientific reports
Published: August 01, 2023
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: April 29, 2022
Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers.
Journal: Frontiers in neuroscience
Published: July 31, 2020
Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.
Journal: International review of neurobiology
Published: July 28, 2019
Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats.
Journal: Experimental neurology
Published: March 27, 2019
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
Journal: Neurobiology of disease
Published: July 27, 2018
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.
Journal: Molecular neurobiology
Published: March 06, 2018
Intranasal Administration of chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease.
Journal: Journal of biomedical nanotechnology
Published: January 27, 2018
Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease.
Journal: Molecular neurobiology
Published: August 26, 2017
Last Updated: 09/26/2026